Webpackaging logo
  • Close

Moving the industry forward

The UK market

With a UK market that is set to hit a staggering £20 billion value by 2020, an ever increasing population, and people living longer than at any other time in history, the demands on that nation's health care system have never been greater, and the opportunities for the pharmaceutical sector have never been more abundant.

Worldwide

The UK isn't alone in this. Worldwide, this sort of symbiotic relationship can only continue to expand and evolve as the pressures that are put upon organizations providing health care naturally increase. While patients turn to their national health services or private insurance to cure them of their ills, the health care sector looks to the pharmaceutical industry to provide solutions

Advances in the early diagnosis of diseases is also contributing to escalating growth in the need for treatments that span a patient's illness, and the demand for increasingly effective new medicines continues to grow. The world is full of fast, technical solutions where consumers can purchase what they want when they want it and information seekers have the answers they need at their fingertips. Those in need of health care solutions are no less demanding and do not want to be patient.

As those in the industry can attest, developing new drugs is a massively expensive and time consuming endeavour, often spanning years of research and costing millions in investment, requiring a vast bank of expertise and years of accumulated knowledge, data, and analysis. The increasing demands and opportunities that the pharmaceutical industry encounters leads to numerous questions, not least of these being this:

How can the industry come together and focus its combined efforts upon meeting these demands and maximizing opportunities?

 

The solution

On April 29th and 30th, the Making Pharmaceuticals event will bring together experts and companies from across the industry over two days to meet, discuss, network, and drive innovation and improvements in the marketplace. The event will focus on outsourcing in the pharmaceutical industry featuring a full range of contract services for licence holders, brand owners, and manufacturers looking for outsourcing options covering the entire process of getting a pharmaceutical to market, from research and clinical trials to manufacturing, from packaging through to delivery and traceability.

The two days of Making Pharmaceuticals will also feature details on product and manufacturing sciences, including all the know-how, expertise, technology, techniques, resources, and systems necessary for products and processes, including critical-to-quality product attributes and process parameters, process capability, manufacturing and process control technologies, and quality system infrastructures.

The exhibition and seminar opens its doors on April 29th at the National Motorcycle Museum, Birmingham, running from 08:45 until 17:30 and then again on April 30th, from 08:45 until 16:00.

Many participants

Over forty companies will be on hand exhibiting their products, services, and solutions. Visitors will also be able to take advantage of 45+ seminars and workshops taking place during the two days, including presentations from Public Health England, the University of Leeds High Value Chemicals Manufacturing Hub, The Pharmaceutical Quality Group, and a two hour workshop being delivered by Dr Duncan Emerton of First Word.

The UK market is set to hit a staggering £20 billion value by 2020

Both the exhibition and all seminar sessions are free to attend, and visitors can register to attend via the Making Pharmaceuticals website. For more information and any other enquiries, interested parties should  contact the organizer's office at +44 (0) 1892 518 877 or send a message to makingpharma@stepex.com.

Making Pharmaceuticals - Moving the industry forward

With a UK market that is set to hit a staggering £20 billion value by 2020, an ever increasing population, and people living longer than at any other time in history, the demands on that nation's health care system have never been greater, and the opportunities for the pharmaceutical sector have never been more abundant.

The UK isn't alone in this. Worldwide, this sort of symbiotic relationship can only continue to expand and evolve as the pressures that are put upon organizations providing health care naturally increase. While patients turn to their national health services or private insurance to cure them of their ills, the health care sector looks to the pharmaceutical industry to provide solutions.

Advances in the early diagnosis of diseases is also contributing to escalating growth in the need for treatments that span a patient's illness, and the demand for increasingly effective new medicines continues to grow. The world is full of fast, technical solutions where consumers can purchase what they want when they want it and information seekers have the answers they need at their fingertips. Those in need of health care solutions are no less demanding and do not want to be patient.

As those in the industry can attest, developing new drugs is a massively expensive and time consuming endeavour, often spanning years of research and costing millions in investment, requiring a vast bank of expertise and years of accumulated knowledge, data, and analysis. The increasing demands and opportunities that the pharmaceutical industry encounters leads to numerous questions, not least of these being this:

How can the industry come together and focus its combined efforts upon meeting these demands and maximizing opportunities?

On April 29th and 30th, the Making Pharmaceuticals event will bring together experts and companies from across the industry over two days to meet, discuss, network, and drive innovation and improvements in the marketplace. The event will focus on outsourcing in the pharmaceutical industry featuring a full range of contract services for licence holders, brand owners, and manufacturers looking for outsourcing options covering the entire process of getting a pharmaceutical to market: from research and clinical trials to manufacturing, from packaging through to delivery and traceability.

The two days of Making Pharmaceuticals will also feature details on product and manufacturing sciences, including all the know-how, expertise, technology, techniques, resources, and systems necessary for products and processes, including critical-to-quality product attributes and process parameters, process capability, manufacturing and process control technologies, and quality system infrastructures.

The exhibition and seminar opens its doors on April 29th at the National Motorcycle Museum, Birmingham, running from 08:45 until 17:30 and then again on April 30th, from 08:45 until 16:00.

Over forty companies will be on hand exhibiting their products, services, and solutions. Visitors will also be able to take advantage of 45+ seminars and workshops taking place during the two days, including presentations from Public Health England, the University of Leeds High Value Chemicals Manufacturing Hub, The Pharmaceutical Quality Group, and a two hour workshop being delivered by Dr Duncan Emerton of First Word.

Both the exhibition and all seminar sessions are free to attend, and visitors can register to attend via the Making Pharmaceuticals website. For more information and any other enquiries, please contact the organizer's office at +44 (0) 1892 518 877 or send a message to makingpharma@stepex.com.

  • Multimedia
  • English
  • Modified 15 Jan 2016
  • Hits 622